In this exciting role, you will be a crucial asset in leading and implementing the online marketing strategy. We are seeking someone with both a creative and analytical mind that excels in digitally-focused strategy, design, and development.
On a day-to-day basis, you will:
We are looking for people who have:
ABOUT NEOTERYX
Founded in 2014, Neoteryx is a medical device company shaping the future of healthcare. Our breakthrough blood collection technology – VAMS® – is used by pharmaceutical giants, organ transplant patients, researchers in economically disadvantaged regions, and others on the leading edge of science and medicine. When you join our fun, tight-knit team, you’ll discover what one drop of blood can do, and be part of microsampling innovations that will change the world.
Watch this video to learn more!
Department: Marketing
Reports to: Director of Marketing
Supervises: N/A
Status: Full Time
Type: Exempt
Schedule: 8am-5pm (PST)
Employee of: Neoteryx LLC
Location: Headquarters - Torrance, CA (USA)
Salary: Competitive, Depending on Experience
Benefits: Offered for Regular Full Time Employees
Travel: N/A
Contact Us
Trajan Scientific Americas Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group.
Copyright © 2022. All rights reserved.